These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28096109)

  • 1. Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study.
    Ahn R; Woodbridge A; Abraham A; Saba S; Korenstein D; Madden E; Boscardin WJ; Keyhani S
    BMJ; 2017 Jan; 356():i6770. PubMed ID: 28096109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary outcome switching among drug trials with and without principal investigator financial ties to industry: a cross-sectional study.
    Jones CW; Misemer BS; Platts-Mills TF; Ahn R; Woodbridge A; Abraham A; Saba S; Korenstein D; Madden E; Keyhani S
    BMJ Open; 2018 Feb; 8(2):e019831. PubMed ID: 29439079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
    Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
    Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study.
    Falk Delgado A; Falk Delgado A
    Trials; 2017 Jul; 18(1):354. PubMed ID: 28747226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial relationships between industry and principal investigators of US cooperative group randomized cancer clinical trials.
    Metzger AL; Kusi Appiah A; Wright CM; Jairam V; Amini A; Park HS; Welsh JW; Thomas CR; Verma V; Ludmir EB
    Int J Cancer; 2021 Nov; 149(9):1683-1690. PubMed ID: 34173669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
    Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
    BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.
    Bero L; Oostvogel F; Bacchetti P; Lee K
    PLoS Med; 2007 Jun; 4(6):e184. PubMed ID: 17550302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of author's financial conflict of interest with characteristics and outcome of rheumatoid arthritis randomized controlled trials.
    Khan NA; Nguyen CL; Khawar T; Spencer H; Torralba KD
    Rheumatology (Oxford); 2019 May; 58(5):776-785. PubMed ID: 30535001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripartite conflicts of interest and high stakes patent extensions in the DSM-5.
    Cosgrove L; Krimsky S; Wheeler EE; Kaitz J; Greenspan SB; DiPentima NL
    Psychother Psychosom; 2014; 83(2):106-13. PubMed ID: 24458102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study.
    Moynihan R; Albarqouni L; Nangla C; Dunn AG; Lexchin J; Bero L
    BMJ; 2020 May; 369():m1505. PubMed ID: 32461201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sponsorship bias in the comparative efficacy of psychotherapy and pharmacotherapy for adult depression: meta-analysis.
    Cristea IA; Gentili C; Pietrini P; Cuijpers P
    Br J Psychiatry; 2017 Jan; 210(1):16-23. PubMed ID: 27810891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.
    Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C
    Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conflicts of interest and outcomes of clinical trials of antidepressants: An 18-year retrospective study.
    Waqas A; Baig AA; Khalid MA; Aedma KK; Naveed S
    J Psychiatr Res; 2019 Sep; 116():83-87. PubMed ID: 31212249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between funding by commercial interests and study outcome in randomized controlled drug trials.
    Yaphe J; Edman R; Knishkowy B; Herman J
    Fam Pract; 2001 Dec; 18(6):565-8. PubMed ID: 11739337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between research sponsorship and study outcome in plastic surgery literature.
    Momeni A; Becker A; Bannasch H; Antes G; Blümle A; Stark GB
    Ann Plast Surg; 2009 Dec; 63(6):661-4. PubMed ID: 19887933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Authors of clinical trials seldom reported details when declaring their individual and institutional financial conflicts of interest: a cross-sectional survey.
    Hakoum MB; Noureldine H; Habib JR; Abou-Jaoude EA; Raslan R; Jouni N; Hasbani DJ; Lopes LC; Guyatt G; Akl EA
    J Clin Epidemiol; 2020 Nov; 127():49-58. PubMed ID: 32512186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
    Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ
    CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with results and conclusions of trials of thiazolidinediones.
    Rattinger G; Bero L
    PLoS One; 2009 Jun; 4(6):e5826. PubMed ID: 19503811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dependability of results in conference abstracts of randomized controlled trials in ophthalmology and author financial conflicts of interest as a factor associated with full publication.
    Saldanha IJ; Scherer RW; Rodriguez-Barraquer I; Jampel HD; Dickersin K
    Trials; 2016 Apr; 17(1):213. PubMed ID: 27113767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.